Video

Kausik Ray, MD: Treating Diabetes During COVID-19

Author(s):

There is concern over whether or not patients are adhering to their treatment during the pandemic.

While there are many options available to treat type 2 diabetes, there is some concern over patient adherence during the coronavirus disease 2019 (COVID-19) pandemic.

With treatment adherence so important for diabetic patients, many doctors are concerned this patient population has not regularly taken or filled their prescriptions.

However, there are new treatments being explored that could really help these patients should they adhere to the prescribed doses.

During the 18th World Congress of Insulin Resistance Diabetes & Cardiovascular (WCIRDC) Online CME Conference presented by the Metabolic Institute of America (TMIOA), Kausik Ray, MD, a professor of Public Health at the School of Public Health of Imperial College London presented new data showing the benefits of bempedoic acid and PCSK9 siRNA (inclisiran).

Currently, bempedoic acid is currently approved in Europe and the US, making it the first cholesterol lowering oral agent approved in approximately 10 years.

However, inclisiran represents an entirely new class of drugs that targets a process called gene silencing. Ray expects this treatment to be available in both North America and Europe in 2021.

Ray explained in an interview with HCPLive®, how concerning the pandemic has been for diabetic patients and why the newer effective treatments could have a major impact on prescription patterns.

Related Videos
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Investigating Brensocatib, Potential First Treatment for Bronchiectasis, with James Chalmers, MBChB, PhD
Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
AI in Dermatology: Emerging Insights and Diverging Perspectives
Skin of Color Savvy: News Update—Addressing Disparities, Black History Month, & Mentorship Opportunities
Medical Sisterhood: James Del Rosso, DO
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Brian Lee, MD | Credit: AASLD
Transformations in Aortic Disease Management with Mehrdad Ghoreishi, MD | Image Credit: Baptist Health South Florida
© 2025 MJH Life Sciences

All rights reserved.